A whistleblower lawsuit accuses Walmart of systematically filling prescriptions without proper authorization, with claims suggesting the practice involved both pharmacists and the company’s compliance team. The allegations span nearly a decade, raising serious questions about patient safety and regulatory oversight. If true, the case could expose widespread failures in pharmacy operations and corporate accountability. Details on the scope and evidence behind the claims remain under scrutiny.
The complaint alleged that Walmart had been filling invalid prescriptions with the knowledge of pharmacists and its compliance team since June 2013.
